ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• A Guide To RTSM For Clinical Trials

  Looking ahead, the evolution of RTSM in clinical trials points towards cloud-based solutions, heightened emphasis on patient safety, and greater collaboration among stakeholders. Learn how you can prepare.

• Decentralized Trials: The Value Of Direct-To-Patient, Pharmacy-Led Solutions

  Pharmacy-led DTP models cut site burden, improve inventory control, and expand trial access. Learn how to optimize your decentralized trial supply chain for compliance and patient outcomes.

• Key Considerations For Labeling Your Cell Or Gene Therapy

  As sponsors focus on maintaining the temperature range required for cell and gene therapies, they must also keep in mind the challenges this task presents when properly labeling them for clinical trial distribution.

• Trade Wars And Geopolitical Conflict: Navigating US Tariff Changes And The War In Iran

  Tariffs and geopolitical disruptions are reshaping supply chains. Companies must act now to strengthen continuity planning, evaluate tariff recovery opportunities, and build more resilient logistics strategies for the future.

• Demonstrating The Value Of Investigational Drug Services Through Time-Based Metrics

  Learn how adopting time-based metrics helps research teams accurately track workload, optimize staffing, and justify trial budgets.

• Overcoming Challenges In Cell And Gene Therapy Containment

  Review the hurdles that can slow your time to market, including the challenges in packaging high-value therapies and solutions to help you mitigate risk and simplify the journey.

• Building A Global Cell And Gene Supply Chain Serving Personalized Medicine

  Clinical distribution paths can be fragile for a multitude of reasons, making it critical that pharmaceutical sponsors and their partners orchestrate supply chain logistics even before site initiation.

• Time, Logistics, And Manufacturing In Autologous Cell Therapy Clinical Trials

  Learn how the establishment of effective guidelines and standardization relevant to cell therapy development can help to minimize delays and lead to more positive outcomes.

• Improving Clinical Trial Label Translation Through Centralized Reuse And Control

  Eliminate workflow inefficiencies and regulatory risk in global trials with a centralized translation framework and validated phrase library for consistent, cost-effective execution.

• GMP Clinical Storage Strategies for Today's Complex Trials

  Temperature‑sensitive therapies need more than basic freezer space. Purpose‑built GMP storage protects product integrity, supports compliance, and adds flexibility as trial complexity grows.